Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer
一项 Ib/II 期随机、开放标签研究，评估多柔比星和环磷酰胺联合或不联合低剂量、短期舒尼替尼用于乳腺癌术前治疗的疗效。
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.11596
Wong, Andrea L A; Sundar, Raghav; Wang, Ting-Ting; Ng, Thian-C; Zhang, Bo; Tan, Sing-Huang; Soh, Thomas I P; Pang, Angela S L; Tan, Chee-Seng; Ow, Samuel G W; Wang, Lingzhi; Mogro, Jannet; Ho, Jingshan; Jeyasekharan, Anand D; Huang, Yiqing; Thng, Choon-Hua; Chan, Ching-Wan; Hartman, Mikael; Iau, Philip; Buhari, Shaik A; Goh, Boon-Cher; Lee, Soo-Chin
